Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience

por Biskup, Ewelina, Sartorius, Céline Montavon, Müller, Andreas, Leo, Cornelia, Nussbaum, Catrina Uhlmann, Georgescu Margarint, Elena Laura, Koychev, Daniel, Schreiber, Alexander, Taverna, Christian, Thorn, David, Vetter, Marcus
Publicado 2023